Generation of a human induced pluripotent stem cell line (PNUYHi004-A) from a patient with hereditary spastic paraplegia type 46 (SPG46) carrying compound heterozygous GBA2 variants
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q4Scopus Q2
- 저널
- STEM CELL RESEARCH97 · #104114 · 2026
- 피인용
- Web of Science 0Scopus 0
- JCR IF
- JCR 2024 0.7
- ISSN
- 1873-5061
저자
- 김태윤제1저자Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Sch Med,Dept Neurol, Yangsan, South Korea
- Lee, NayeonCheongju Univ, Dept Biopharmaceut Sci, Cheongju, South Korea
- 정나연Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Sch Med,Dept Neurol, Yangsan, South Korea
- 이재혁교신저자Pusan Natl Univ, Yangsan Hosp, Res Inst Convergence Biomed Sci & Technol, Sch Med,Dept Neurol, Yangsan, South Korea
초록
SPG46 is a rare autosomal recessive form of hereditary spastic paraplegia (HSP) caused by biallelic pathogenic variants in GBA2, encoding the non-lysosomal glucosylceramidase. We generated an induced pluripotent stem cell (iPSC) line from peripheral blood mononuclear cells of a 40-year-old Korean patient with adult-onset complicated HSP carrying novel compound heterozygous GBA2 variants (NM_020944.3: c.2059_2072del, p.Tyr687ValfsTer23; c.2621C > T, p.Ser874Leu), using non-integrating Sendai virus vectors. The iPSC line showed a normal karyotype, expressed markers of undifferentiated hPSC, and differentiated into all three germ layers. This line provides a resource for studying GBA2-associated SPG46 and sphingolipid-related neurodegeneration.
키워드
식별자
- Scopus EID
- 2-s2.0-105052749517
- WoS UID
- 001903514700001



로그인
연구물 목록으로